Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10486013 | 0.98 | MEN1 (0.47) | MEN1KMT2AKDM4CSLC2A1L3MBTL1 | |
| SCHEMBL16264036 | 0.98 | MEN1 (0.47) | MEN1KMT2AKDM4CSLC2A1L3MBTL1 | |
| SCHEMBL8459105 | 0.98 | MEN1 (0.47) | MEN1KMT2AKDM4CSLC2A1L3MBTL1 | |
| SCHEMBL21667954 | 0.98 | MEN1 (0.47) | MEN1KMT2AKDM4CSLC2A1L3MBTL1 | |
| SCHEMBL21668019 | 0.98 | MEN1 (0.47) | MEN1KMT2AKDM4CSLC2A1L3MBTL1 | |
| SCHEMBL14363514 | 0.97 | MEN1 (0.45) | MEN1KMT2AKDM4CSLC2A1L3MBTL1 | |
| SCHEMBL10486622 | 0.97 | MEN1 (0.45) | MEN1KMT2AKDM4CSLC2A1L3MBTL1 | |
| SCHEMBL20429037 | 0.91 | MEN1 (0.40) | MEN1KMT2AKDM4CSLC2A1L3MBTL1 | |
| SCHEMBL11917953 | 0.90 | MEN1 (0.43) | MEN1KMT2AKDM4CSLC2A1L3MBTL1 | |
| SCHEMBL497200 | 0.89 | KDM4C (0.43) | MEN1KMT2AKDM4CL3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11639330-B2 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | SHOWA DENKO K.K. (JP) | 2023-05-02 | — | — | US | disclosed |
| US-11639330-B2 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | SHOWA DENKO K.K. (JP) | 2023-05-02 | — | — | US | disclosed |
| US-20210188766-A1 | FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM | SHOWA DENKO K.K. (JP) | 2021-06-24 | — | — | US | disclosed |
| EP-3421447-B1 | FATTY ACID COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI INST MATERIA MEDICA CAS (CN) | 2021-03-24 | — | — | EP | disclosed |
| US-9012500-B2 | PKC-ε activator | NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE (JP) | 2015-04-21 | — | — | US | disclosed |
| WO-2010031184-A1 | AZAINDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | MERCK FROSST CANADA LTD. (CA) | 2010-03-25 | — | — | WO | disclosed |
| US-5153214-A | Treating cardiovascular disorders | CIBA-GEIGY CORPORATION (US) | 1992-10-06 | — | — | US | disclosed |
| US-5025025-A | Cardiovascular disorders | CIBA-GEIGY CORPORATION (US) | 1991-06-18 | — | — | US | disclosed |
| EP-0405391-A1 | Certain (arylsulfonamido- and pyridyl- or imidazolyl-)-substituted carboxylic acids and derivatives thereof | CIBA-GEIGY AG (CH) | 1991-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639330-B2 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | AFF1, PHOSPHO1, CHRM1 | MEN1 368/4885KMT2A 797/4885KDM4C 1926/4885 |
| US-20210188766-A1 | FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM | AFF1, PHOSPHO1, CHRM1 | MEN1 368/4885KMT2A 797/4885KDM4C 1926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.